These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34873305)

  • 1. Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma.
    Wang H; Zhai C; Zhang C; Liu Q; Zhang H; Sun X; Lin L; Yu H; Wang D
    Mod Pathol; 2022 May; 35(5):594-600. PubMed ID: 34873305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
    Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
    Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
    Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
    Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
    Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
    Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
    Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
    [No Abstract]   [Full Text] [Related]  

  • 6. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
    Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
    Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
    Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
    Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
    Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
    Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
    Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
    Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
    Skaugen JM; Seethala RR; Chiosea SI; Landau MS
    Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma.
    Shi Q; Zhang B; Bsirini C; Li L; Giampoli EJ; Magliocca KR; Reid M; Zhou Z
    Hum Pathol; 2022 Sep; 127():86-91. PubMed ID: 35700750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.
    Haller F; Moskalev EA; Kuck S; Bieg M; Winkelmann C; Müller SK; Ihrler S; Märkl B; Eils R; Wiemann S; Iro H; Hartmann A; Agaimy A
    Am J Surg Pathol; 2020 Sep; 44(9):1290-1292. PubMed ID: 32341238
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.
    Viswanathan K; Beg S; He B; Zhang T; Cantley R; Lubin DJ; Shi Q; Maleki Z; Asiry S; Rao R; Katabi N; Nakaguro M; Faquin WC; Sadow PM; Siddiqui MT; Scognamiglio T
    Am J Clin Pathol; 2022 Jan; 157(1):98-108. PubMed ID: 34508546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
    Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
    Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
    Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
    Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
    Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP; Jo VY; Hornick JL
    Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
    Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
    J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the Spectrum of NR4A3 Fusion-Positive Gynecologic Leiomyosarcomas.
    Momeni-Boroujeni A; Mullaney K; DiNapoli SE; Leitao MM; Hensley ML; Katabi N; Allison DHR; Park KJ; Antonescu CR; Chiang S
    Mod Pathol; 2024 May; 37(5):100474. PubMed ID: 38508521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.